Woodman, C.B., Collins, S.I., Young, L.S. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 2007, 7, 11-22.
Roberts, J.N., Buck, C.B., Thompson, C.D., Kines, R., Bernardo, M., Choyke, P.L., Lowy, D.R., Schiller, J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13, 857-861.
Marsh, M. Original site of cervical carcinoma, topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction. Obstet. Gynecol. 1956, 7, 444-452.
Richart, R.M. Cervical intraepithelial neoplasia. Pathol. Ann. 1973, 8, 301-328.
Forman, D., de Martel, C., Lacey, C.J., Soerjomataram, I., Lortet Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., Franceschi, S. Global burden of human papillomavirus and related diseases. Vaccine 2012, 30 (Suppl 5), F12-F23.
Martens, J.E., Arends, J., Van der Linden, P.J., De Boer, B.A., Helmerhorst, T.J. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res. 2004, 24, 771-775.
Martens, J.E., Smedts, F.M., Ploeger, D., Helmerhorst, T.J., Ramaekers, F.C., Arends, J.W., Hopman, A.H. Distribution pattern and marker profile show two subpopulations of reserve cells in the endocervical canal. Int. J. Gynecol. Pathol. 2009, 28, 381-388.
Chin, N., Platt, A.B., Nuovo, G.J. Squamous intraepithelial lesions arising in benign endocervical polyps: A report of 9 cases with correlation to the Pap smears, HPV analysis, and immunoprofile. Int. J. Gynecol. Pathol. 2008, 27, 582-590.
Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M.R., McLaughlin-Drubin, M.E., Munger, K., Feldman, S., McKeon, F.D., Xian, W., et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl. Acad. Sci. USA 2012, 109, 10516-10521.
Herfs, M., Vargas, S.O., Yamamoto, Y., Howitt, B.E., Nucci, M.R., Hornick, J.L., McKeon, F.D., Xian, W., Crum, C.P. A novel blueprint for ‘top down’ differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J. Pathol. 2013, 229, 460-468.
Wang, X., Ouyang, H., Yamamoto, Y., Kumar, P.A., Wei, T.S., Dagher, R., Vincent, M., Lu, X., Bellizzi, A.M., Ho, K.Y., et al. Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell 2011, 145, 1023-1035.
Paquette, C., Mills, A.M., Stoler, M.H. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion. Am. J. Surg. Pathol. 2016, 40, 236-243.
Mills, A.M., Paquette, C., Terzic, T., Castle, P.E., Stoler, M.H. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials. Am. J. Surg. Pathol. 2017, 41, 143-152.
Huang, E.C., Tomic, M.M., Hanamornroongruang, S., Meserve, E.E., Herfs, M., Crum, C.P. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: A case series, literature review and commentary. Mod. Pathol. 2016, 29, 1501-1510.
Peng, X., Wu, Z., Yu, L., Li, J., Xu, W., Chan, H.C., Zhang, Y., Hu, L. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis. Gynecol. Oncol. 2012, 125, 470-476.
Lee, H., Lee, H., Cho, Y.K. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis. Diagn. Pathol. 2017, 12, 18.
Mirkovic, J., Howitt, B.E., Roncarati, P., Demoulin, S., Suarez-Carmona, M., Hubert, P., McKeon, F.D., Xian, W., Li, A., Delvenne, P., et al. Carcinogenic HPV infection in the cervical squamo-columnar junction. J. Pathol. 2015, 236, 265-271.
Yarbrough, V.L., Winkle, S., Herbst-Kralovetz, M.M. Antimicrobial peptides in the female reproductive tract: A critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Updat. 2015, 21, 353-377.
Suarez-Carmona, M., Hubert, P., Delvenne, P., Herfs, M. Defensins: “Simple” antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev. 2015, 26, 361-370.
Hancock, R.E., Haney, E.F., Gill, E.E. The immunology of host defence peptides: Beyond antimicrobial activity. Nat. Rev. Immunol. 2016, 16, 321-334.
Buck, C.B., Day, P.M., Thompson, C.D., Lubkowski, J., Lu, W., Lowy, D.R., Schiller, J.T. Human α-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. USA 2006, 103, 1516-1521.
Hubert, P., Herman, L., Maillard, C., Caberg, J.H., Nikkels, A., Pierard, G., Foidart, J.M., Noel, A., Boniver, J., Delvenne, P. Defensins induce the recruitment of dendritic cells in cervical human papillomavirusassociated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB J. 2007, 21, 2765-2775.
Zhao, S., Zhou, H.Y., Li, H., Yi, T., Zhao, X. The therapeutic impact of HNP-1 in condyloma acuminatum. Int. J. Dermatol. 2015, 54, 1205-1210.
Hubert, P., Herman, L., Roncarati, P., Maillard, C., Renoux, V., Demoulin, S., Erpicum, C., Foidart, J.M., Boniver, J., Noel, A., et al. Altered α-defensin 5 expression in cervical squamocolumnar junction: Implication in the formation of a viral/tumour-permissive microenvironment. J. Pathol. 2014, 234, 464-477.
Wiens, M.E., Smith, J.G. α-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection. J. Virol. 2015, 89, 2866-2874.
Nguyen, E.K., Nemerow, G.R., Smith, J.G. Direct evidence from single-cell analysis that human α-defensins block adenovirus uncoating to neutralize infection. J. Virol. 2010, 84, 4041-4049.
Zins, S.R., Nelson, C.D., Maginnis, M.S., Banerjee, R., O’Hara, B.A., Atwood, W.J. The human α-defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. J. Virol. 2014, 88, 948-960.
Smith, J.G., Nemerow, G.R. Mechanism of adenovirus neutralization by Human α-defensins. Cell Host Microbe 2008, 3, 11-19.
Wiens, M.E., Smith, J.G. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome. mBio 2017, 8, e02304-e02316.
Day, P.M., Schelhaas, M. Concepts of papillomavirus entry into host cells. Curr. Opin. Virol. 2014, 4, 24-31.
Grassel, L., Fast, L.A., Scheffer, K.D., Boukhallouk, F., Spoden, G.A., Tenzer, S., Boller, K., Bago, R., Rajesh, S., Overduin, M., et al. The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Sci. Rep. 2016, 6, 32337.
McBride, A.A. The papillomavirus E2 proteins. Virology 2013, 445, 57-79.
Thierry, F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384, 375-379.
Wang, X., Meyers, C., Wang, H.K., Chow, L.T., Zheng, Z.M. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J. Virol. 2011, 85, 8080-8092.
Chen, J., Xue, Y., Poidinger, M., Lim, T., Chew, S.H., Pang, C.L., Abastado, J.P., Thierry, F. Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression. Virology 2014, 462-463, 14-24.
Taguchi, A., Nagasaka, K., Kawana, K., Hashimoto, K., Kusumoto-Matsuo, R., Plessy, C., Thomas, M., Nakamura, H., Bonetti, A., Oda, K., et al. Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology. J. Virol. 2015, 89, 2448-2452.
Schmitt, M., Dalstein, V., Waterboer, T., Clavel, C., Gissmann, L., Pawlita, M. The HPV16 transcriptome in cervical lesions of different grades. Mol. Cell. Probes 2011, 25, 260-265.
Kanduc, D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit α1-globin and human cytokeratin 7. J. Virol. 2002, 76, 7040-7048.
Favia, G., Kanduc, D., Lo Muzio, L., Lucchese, A., Serpico, R. Possible association between HPV16 E7 protein level and cytokeratin 19. Int. J. Cancer 2004, 111, 795-797.
Herfs, M., Longuespee, R., Quick, C.M., Roncarati, P., Suarez-Carmona, M., Hubert, P., Lebeau, A., Bruyere, D., Mazzucchelli, G., Smargiasso, N., et al. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. J. Pathol. 2017, 241, 522-533.
Gorodeski, G.I., Hopfer, U., Liu, C.C., Margles, E. Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells. Endocrinology 2005, 146, 816-824.
Herfs, M., Hubert, P., Kholod, N., Caberg, J.H., Gilles, C., Berx, G., Savagner, P., Boniver, J., Delvenne, P. Transforming growth factor-β1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am. J. Pathol. 2008, 172, 1391-1402.
Hubert, P., Caberg, J.H., Gilles, C., Bousarghin, L., Franzen-Detrooz, E., Boniver, J., Delvenne, P. Ecadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol. 2005, 206, 346-355.
Jiang, A., Bloom, O., Ono, S., Cui, W., Unternaehrer, J., Jiang, S., Whitney, J.A., Connolly, J., Banchereau, J., Mellman, I. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007, 27, 610-624.
Mayumi, N., Watanabe, E., Norose, Y., Watari, E., Kawana, S., Geijtenbeek, T.B., Takahashi, H. E-cadherin interactions are required for Langerhans cell differentiation. Eur. J. Immunol. 2013, 43, 270-280.
Herfs, M., Herman, L., Hubert, P., Minner, F., Arafa, M., Roncarati, P., Henrotin, Y., Boniver, J., Delvenne, P. High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol. Immunother. CII 2009, 58, 603-614.
Demoulin, S.A., Somja, J., Duray, A., Guenin, S., Roncarati, P., Delvenne, P.O., Herfs, M.F., Hubert, P.M. Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion. Oncoimmunology 2015, 4, e1008334.
Demoulin, S., Herfs, M., Somja, J., Roncarati, P., Delvenne, P., Hubert, P. HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. Int. J. Cancer 2015, 137, 345-358.
Brown, D.R., Schroeder, J.M., Bryan, J.T., Stoler, M.H., Fife, K.H. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J. Clin. Microbiol. 1999, 37, 3316-3322.
Alves de Sousa, N.L., Alves, R.R., Martins, M.R., Barros, N.K., Ribeiro, A.A., Zeferino, L.C., Dufloth, R.M., Rabelo-Santos, S.H. Cytopathic effects of human papillomavirus infection and the severity of cervical intraepithelial neoplasia: A frequency study. Diagn. Cytopathol. 2012, 40, 871-875.
Vrdoljak-Mozetic, D., Krasevic, M., Versa Ostojic, D., Stemberger-Papic, S., Rubesa-Mihaljevic, R., Bubonja-Sonje, M. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions. Cytopathology 2015, 26, 10-18.
Ceballos, K.M., Chapman, W., Daya, D., Julian, J.A., Lytwyn, A., McLachlin, C.M., Elit, L. Reproducibility of the histological diagnosis of cervical dysplasia among pathologists from 4 continents. Int. J. Gynecol. Pathol. 2008, 27, 101-107.
Dalla Palma, P., Giorgi Rossi, P., Collina, G., Buccoliero, A.M., Ghiringhello, B., Gilioli, E., Onnis, G.L., Aldovini, D., Galanti, G., Casadei, G., et al. The reproducibility of CIN diagnoses among different pathologists: Data from histology reviews from a multicenter randomized study. Am. J. Clin. Pathol. 2009, 132, 125-132.
Herfs, M., Crum, C.P. Laboratory management of cervical intraepithelial neoplasia: Proposing a new paradigm. Adv. Anat. Pathol. 2013, 20, 86-94.
Park, J.J., Sun, D., Quade, B.J., Flynn, C., Sheets, E.E., Yang, A., McKeon, F., Crum, C.P. Stratified mucinproducing intraepithelial lesions of the cervix: Adenosquamous or columnar cell neoplasia? Am. J. Surg. Pathol. 2000, 24, 1414-1419.
Crum, C.P. Contemporary theories of cervical carcinogenesis: The virus, the host, and the stem cell. Mod. Pathol. 2000, 13, 243-251.
Smotkin, D., Berek, J.S., Fu, Y.S., Hacker, N.F., Major, F.J., Wettstein, F.O. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet. Gynecol. 1986, 68, 241-244.
Witkiewicz, A.K., Hecht, J.L., Cviko, A., McKeon, F.D., Ince, T.A., Crum, C.P. Microglandular hyperplasia: A model for the de novo emergence and evolution of endocervical reserve cells. Hum. Pathol. 2005, 36, 154-161.
Palefsky, J.M., Giuliano, A.R., Goldstone, S., Moreira, E.D., Jr., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M.H., et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N. Engl. J. Med. 2011, 365, 1576-1585.
Lehtinen, M., Paavonen, J., Wheeler, C.M., Jaisamrarn, U., Garland, S.M., Castellsague, X., Skinner, S.R., Apter, D., Naud, P., Salmeron, J., et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet. Oncol. 2012, 13, 89-99.
Munoz, N., Kjaer, S.K., Sigurdsson, K., Iversen, O.E., Hernandez-Avila, M., Wheeler, C.M., Perez, G., Brown, D.R., Koutsky, L.A., Tay, E.H., et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J. Natl. Cancer Inst. 2010, 102, 325-339.
Schiller, J.T., Castellsague, X., Garland, S.M. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012, 30 (Suppl 5), F123-F138.
De Sanjose, S., Diaz, M., Castellsague, X., Clifford, G., Bruni, L., Munoz, N., Bosch, F.X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect. Dis. 2007, 7, 453-459.
Chesson, H.W., Ekwueme, D.U., Saraiya, M., Watson, M., Lowy, D.R., Markowitz, L.E. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012, 30, 6016-6019.
Massad, L.S., Einstein, M.H., Huh, W.K., Katki, H.A., Kinney, W.K., Schiffman, M., Solomon, D., Wentzensen, N., Lawson, H.W., Conference, A.C.G. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet. Gynecol. 2013, 121, 829-846.
Sagasta, A., Castillo, P., Saco, A., Torne, A., Esteve, R., Marimon, L., Ordi, J., Del Pino, M. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod. Pathol. 2016, 29, 51-59.
Liao, G.D., Sellors, J.W., Sun, H.K., Zhang, X., Bao, Y.P., Jeronimo, J., Chen, W., Zhao, F.H., Song, Y., Cao, Z., et al. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: A prospective study in China. Int. J. Cancer 2014, 134, 1715-1724.
Matsumoto, K., Oki, A., Furuta, R., Maeda, H., Yasugi, T., Takatsuka, N., Mitsuhashi, A., Fujii, T., Hirai, Y., Iwasaka, T., et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study. Int. J. Cancer 2011, 128, 2898-2910.
Pajtler, M., Milicic-Juhas, V., Milojkovic, M., Topolovec, Z., Curzik, D., Mihaljevic, I. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2. Coll. Antropol. 2010, 34, 81-86.
Gravitt, P.E., Kovacic, M.B., Herrero, R., Schiffman, M., Bratti, C., Hildesheim, A., Morales, J., Alfaro, M., Sherman, M.E., Wacholder, S., et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int. J. Cancer 2007, 121, 2787-2793.
Dalstein, V., Riethmuller, D., Pretet, J.L., Le Bail Carval, K., Sautiere, J.L., Carbillet, J.P., Kantelip, B., Schaal, J.P., Mougin, C. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int. J. Cancer 2003, 106, 396-403.
Hesselink, A.T., Berkhof, J., Heideman, D.A., Bulkmans, N.W., van Tellingen, J.E., Meijer, C.J., Snijders, P.J. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int. J. Cancer 2009, 124, 381-386.
Xi, L.F., Koutsky, L.A., Castle, P.E., Wheeler, C.M., Galloway, D.A., Mao, C., Ho, J., Kiviat, N.B. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J. Natl. Cancer Inst. 2009, 101, 153-161.
Holowaty, P., Miller, A.B., Rohan, T., To, T. Natural history of dysplasia of the uterine cervix. J. Natl. Cancer Inst. 1999, 91, 252-258.
Schlecht, N.F., Platt, R.W., Duarte-Franco, E., Costa, M.C., Sobrinho, J.P., Prado, J.C., Ferenczy, A., Rohan, T.E., Villa, L.L., Franco, E.L. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 2003, 95, 1336-1343.
Herfs, M., Crum, C.P. Cervical cancer: Squamocolumnar junction ablation--tying up loose ends? Nat. Rev. Clin. Oncol. 2015, 12, 378-380.
Herfs, M., Somja, J., Howitt, B.E., Suarez-Carmona, M., Kustermans, G., Hubert, P., Doyen, J., Goffin, F., Kridelka, F., Crum, C.P., et al. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction. Int. J. Cancer 2015, 136, 1043-1052.
Franceschi, S. Past and future of prophylactic ablation of the cervical squamocolumnar junction. Ecancermedicalscience 2015, 9, 527.
Younge, P.A. Cancer of the uterine cervix, a preventable disease. Obstet. Gynecol. 1957, 10, 469-481.
Peyton, F.W., Peyton, R.R., Anderson, V.L., Pavnica, P. The importance of cauterization to maintain a healthy cervix. Long-term study from a private gynecologic practice. Am. J. Obstet. Gynecol. 1978, 131, 374-380.
Kauraniemi, T., Rasanen-Virtanen, U., Hakama, M. Risk of cervical cancer among an electrocoagulated population. Am. J. Obstet. Gynecol. 1978, 131, 533-538.
Taylor, S., Wang, C., Wright, T.C., Denny, L., Tsai, W.Y., Kuhn, L. Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: Results from a randomized trial in South Africa. BMC Med. 2010, 8, 40.
Kocken, M., Helmerhorst, T.J., Berkhof, J., Louwers, J.A., Nobbenhuis, M.A., Bais, A.G., Hogewoning, C.J., Zaal, A., Verheijen, R.H., Snijders, P.J., et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study. Lancet Oncol. 2011, 12, 441-450.
Herfs, M., Hubert, P., Moutschen, M., Delvenne, P. Mucosal junctions: Open doors to HPV and HIV infections? Trends Microbiol. 2011, 19, 114-120.
Auvert, B., Lissouba, P., Cutler, E., Zarca, K., Puren, A., Taljaard, D. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J. Acquir. Immune Defic. Syndr. 2010, 53, 111-116.
Lissouba, P., Van de Perre, P., Auvert, B. Association of genital human papillomavirus infection with HIV acquisition: A systematic review and meta-analysis. Sex. Transm. Infect. 2013, 89, 350-356.
Averbach, S.H., Gravitt, P.E., Nowak, R.G., Celentano, D.D., Dunbar, M.S., Morrison, C.S., Grimes, B., Padian, N.S. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. Aids 2010, 24, 1035-1042.
Smith-McCune, K.K., Shiboski, S., Chirenje, M.Z., Magure, T., Tuveson, J., Ma, Y., Da Costa, M., Moscicki, A.B., Palefsky, J.M., Makunike-Mutasa, R., et al. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS ONE 2010, 5, e10094.
Tommasino, M. The biology of beta human papillomaviruses. Virus Res. 2017, 231, 128-138.
Viarisio, D., Mueller-Decker, K., Kloz, U., Aengeneyndt, B., Kopp-Schneider, A., Grone, H.J., Gheit, T., Flechtenmacher, C., Gissmann, L., Tommasino, M. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog. 2011, 7, e1002125.
Mirabello, L., Yeager, M., Cullen, M., Boland, J.F., Chen, Z., Wentzensen, N., Zhang, X., Yu, K., Yang, Q., Mitchell, J., et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. J. Natl. Cancer Inst. 2016, 108, doi:0.1093/jnci/djw100.
Pirog, E.C., Kleter, B., Olgac, S., Bobkiewicz, P., Lindeman, J., Quint, W.G., Richart, R.M., Isacson, C. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am. J. Pathol. 2000, 157, 1055-1062.
Kajitani, N., Satsuka, A., Kawate, A., Sakai, H. Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation. Front. Microbiol. 2012, 3, 152.
